Am J Transplant, Volume 19, Suppl 3 Archives - Page 167 of 214 - ATC Abstracts

2019 American Transplant Congress
Phylogenetic Analysis of the Epstein Barr Virus Nuclear Antigen-1 and Associated Correlates among Canadian Transplant Patients
M. Abdulnoor¹, S. Isabel¹, T. Paton¹, N. Khodai-Booran¹, T. Schechter¹, P. Birk², T. Blydt-Hansen³, B. Foster⁴, S. Mital¹, V. Phan⁵, S. Urschel⁶, G. Casallo¹, T. Papaz¹, L. Hamiwka⁷, S. Min¹, U. Allen¹
¹University of Toronto, Toronto, ON, Canada, ²University of Manitoba, Winnipeg, MB, Canada, ³University of British Columbia, Vancouver, BC, Canada, ⁴McGill University, Montreal, QC, Canada, ⁵University of Montreal, Montreal, QC, Canada, ⁶University of Alberta, Edmonton, AB, Canada, ⁷University of Calgary, Calgary, AB, Canada
*Purpose: The effect of the genetic diversity of the Epstein-Barr virus (EBV) on clinical outcomes in the transplant setting is important to study. We examined…
2019 American Transplant Congress
Infective Complications after Renal Transplantation – A Single Centre Experience Comparing Alemtuzumab to Basiliximab Induction
R. Czajka, M. Welberry Smith, M. Gittus, E. Lindley, M. Vernon
Renal Medicine, St James' University Hospital, Leeds, United Kingdom
*Purpose: Our centre predominantly uses alemtuzumab as induction immunosuppression for renal transplantation. We examined infective complications after renal transplantation, comparing different induction, and maintenance, immunosuppression…
2019 American Transplant Congress
Phenotype and Course of Renal Tubular Cell Death during Cold Ischemia versus Cold Ischemia Followed by Transplant
S. Jain¹, R. Plenter², T. Nydam², A. Jani¹
¹Renal Division, University of Colorado, Aurora, CO, ²Transplant Microsurgery Program, University of Colorado, Aurora, CO
*Purpose: Treatments of Delayed graft function (DGF) are lacking. Prolonged cold ischemia (CI) is a risk factor for DGF but the pathways by which CI…
2019 American Transplant Congress
Histone Deacetylase-8 (HDAC8) Inhibition is Protective in a Murine Model of Renal Ischemia Reperfusion Injury (IRI)
P. T. Hernandez¹, S. J. Concors¹, D. D. Aufhauser¹, L. Krumeich¹, Z. Wang¹, G. Ge¹, A. Beeler², M. Levine¹, W. Hancock³
¹Hospital of the University of Pennsylvania, Philadelphia, PA, ²Chemistry, Boston University, Boston, MA, ³Children's Hospital of Philadelphia, Philadelphia, PA
*Purpose: IRI is a major source of morbidity after renal transplantation, contributing to poor transplant outcomes and decreased graft survival. Histone deacetylases (HDACs) are enzymes…
2019 American Transplant Congress
Urinary Podocin mRNA as Predictor of Renal Allograft Function Decline
A. Naik¹, J. Aqeel¹, D. Cibrik², M. Samaniego³, L. Wickman¹, S. Wang¹, M. Chowdhury¹, R. Wiggins¹
¹University of Michigan, Ann Arbor, MI, ²University of Kansas, Kansas City, KS, ³Henry Ford, Detroit, MI
*Purpose: Traditional biomarkers (such as proteinuria, 1year eGFR) as well as validated risk prediction tools such as the Birmingham Risk Score predict risk of ESRD.…
2019 American Transplant Congress
The Value of SCS Perfusate Biomarkers for Predicting DGF of DCD Donor Kidneys
X. Li, W. Wang, X. Zhang
Beijing Chaoyang Hospital, Capital Medical University, Beijing, China
*Purpose: To explore the possibilities of simple cold stored(SCS) perfusate biomarkers predicting delayed graft function(DGF) in donor of cardiac death (DCD) kidneys.*Methods: A total of…
2019 American Transplant Congress
Chemokine Ligand 14 is a Novel Therapeutic Target in Kidney Fibrosis
S. Lee¹, Y. Kim¹, J. Moon¹, H. Lee¹, S. Han¹, J. Lee², R. Cha³, D. Kim¹, C. Lee⁴, K. Kim⁵, Y. Kim¹, S. Yang⁶
¹Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of, ²Internal Medicine, Boramae Medical Center, Seoul, Korea, Republic of, ³Internal Medicine, National Medical Center, Seoul, Korea, Republic of, ⁴Internal Medicine, Cheju Halla University Hospital, Jeju, Korea, Republic of, ⁵Biomedical Science, Seoul National University, Seoul, Korea, Republic of, ⁶Seoul National University College of Medicine, Seoul, Korea, Republic of
*Purpose: Chemokine ligand 14 (CCL14), a ligand for CCR1, has been known as a M2 polarizing marker and chemotactic cytokine, which is expressed by fibroblast,…
2019 American Transplant Congress
Outcome Of Late Biopsy-negative Rejection After Heart Transplantation
M. Kittleson, J. Patel, E. Kransdorf, S. Dimbil, R. Levine, J. A. Kobashigawa
Cedars-Sinai Smidt Heart Institute, Los Angeles, CA
*Purpose: Biopsy-negative rejection (BNR) is an entity where the endomyocardial biopsy (EMB) shows no findings of rejection, but there is proven cardiac dysfunction i.e. low…
2019 American Transplant Congress
Outcome Of Left Main Stenting After Heart Transplantation
S. Dimbil, J. Patel, B. Azarbal, M. Kittleson, R. Levine, D. H. Chang, J. A. Kobashigawa
Cedars-Sinai Smidt Heart Institute, Los Angeles, CA
*Purpose: Cardiac allograft vasculopathy (CAV) is one of the major factors limiting long-term survival after HTx. The use of angioplasty and drug-eluting stents is common…
2019 American Transplant Congress
Intravenous Methamphetamine Does Not Appear To Be A Contraindication For Heart Donation In Heart Transplantation
A. Velleca, J. Patel, M. Kittleson, R. Levine, S. Dimbil, S. Mersola, M. Hamilton, F. Esmailian, J. A. Kobashigawa
Cedars-Sinai Smidt Heart Institute, Los Angeles, CA
*Purpose: Intravenous methamphetamine (IV meth) use in potential heart donors has been of concern due to the possibility of methamphetamine cardiomyopathy and transmission of infections.…